Andrea Miller
Family Medicine · Eldorado, ILNPI 1750333241
Payments from drug & device makers
Across 397 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$919
- Lilly USA, LLC$513
- Pfizer$424
- Novo Nordisk$354
- GSK$325
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,34199%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $1,036 |
| AstraZeneca | 56 | $919 |
| Lilly USA, LLC | 29 | $513 |
| Pfizer | 28 | $424 |
| Novo Nordisk | 20 | $354 |
| GSK | 21 | $325 |
| Novartis | 19 | $308 |
| Johnson & Johnson | 19 | $288 |
| Merck | 21 | $275 |
| Astellas Pharma US Inc | 7 | $164 |
| Vanda Pharmaceuticals Inc. | 6 | $152 |
| Boehringer Ingelheim | 10 | $149 |
| E.r. Squibb & Sons, L.L.C. | 9 | $135 |
| Abbott | 9 | $131 |
| Dexcom, Inc. | 7 | $127 |
| Amgen | 8 | $119 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Neurocrine Biosciences, Inc. | 5 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $81 |
| Alkermes, Inc. | 4 | $76 |
| Exact Sciences | 3 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Nestle Healthcare Nutrition Inc. | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Radius Health, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 2 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Gilead | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Sanofi | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$6,407 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 107 | $108,889 |
| EliquisApixaban | 129 | $77,689 |
| JanuviaSitagliptin Phosphate | 92 | $75,173 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 70 | $58,175 |
| TrulicityDulaglutide | 53 | $58,159 |
| MounjaroTirzepatide | 56 | $57,072 |
| JardianceEmpagliflozin | 58 | $47,261 |
| MyrbetriqMirabegron | 29 | $22,888 |
| XareltoRivaroxaban | 25 | $18,463 |
| VraylarCariprazine Hcl | 12 | $17,659 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $10,730 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $8,155 |
| LinzessLinaclotide | 15 | $7,825 |
| OxycontinOxycodone Hcl | 19 | $7,585 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 306 | $7,540 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $513 | $115,231109 claims |
| Novo NordiskOzempic | $354 | $108,889107 claims |
| PfizerEliquis, Prempro | $424 | $80,729142 claims |
| MerckJanuvia | $275 | $75,17392 claims |
| GSKTrelegy Ellipta, Arexvy | $325 | $62,81086 claims |
| Boehringer IngelheimJardiance | $149 | $47,26158 claims |
| AbbVieVraylar, Linzess | $1,036 | $25,48327 claims |
| Astellas Pharma US IncMyrbetriq | $164 | $22,88829 claims |
| Johnson & JohnsonXarelto | $288 | $18,46325 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $45 | $4,36112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Eldorado
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.